The Nasdaq Biotechnology Index fell 2.6% as Fulcrum Therapeutics shares and Abivax American Depositary Receipts (ADRs) plummeted following the release of trial results.

2026-06-02

The Nasdaq Biotechnology Index fell 2.6% as Fulcrum Therapeutics shares and Abivax American Depositary Receipts (ADRs) plummeted following the release of trial results.